130 related articles for article (PubMed ID: 8884065)
1. Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclasses are preferred targets.
Hofer G; Lichtenberg D; Kostner GM; Hermetter A
Clin Biochem; 1996 Oct; 29(5):445-50. PubMed ID: 8884065
[TBL] [Abstract][Full Text] [Related]
2. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro.
Reiss D; Beyer K; Engelmann B
Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):807-14. PubMed ID: 9169616
[TBL] [Abstract][Full Text] [Related]
3. Plasmalogen oxidation in human serum lipoproteins.
Felde R; Spiteller G
Chem Phys Lipids; 1995 Jun; 76(2):259-67. PubMed ID: 7634364
[TBL] [Abstract][Full Text] [Related]
4. Transfer of phospholipase A-resistant pyrene-dialkyl-glycerophosphocholine to plasma lipoproteins: differences between Lp[a] and LDL.
Gorges R; Hofer G; Sommer A; Stütz H; Grillhofer H; Kostner GM; Paltauf F; Hermetter A
J Lipid Res; 1995 Feb; 36(2):251-9. PubMed ID: 7751812
[TBL] [Abstract][Full Text] [Related]
5. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins.
Engelmann B; Bräutigam C; Thiery J
Biochem Biophys Res Commun; 1994 Nov; 204(3):1235-42. PubMed ID: 7980601
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.
Wallner S; Orsó E; Grandl M; Konovalova T; Liebisch G; Schmitz G
PLoS One; 2018; 13(10):e0205706. PubMed ID: 30308051
[TBL] [Abstract][Full Text] [Related]
7. Composition of plasmalogens in serum lipoproteins from patients with non-alcoholic steatohepatitis and their susceptibility to oxidation.
Ikuta A; Sakurai T; Nishimukai M; Takahashi Y; Nagasaka A; Hui SP; Hara H; Chiba H
Clin Chim Acta; 2019 Jun; 493():1-7. PubMed ID: 30796899
[TBL] [Abstract][Full Text] [Related]
8. Apoprotein-phospholipid interactions in Lp(a).
Hermetter A; Sommer A; Gorges R; Prenner E; Kostner GM; Paltauf F
Chem Phys Lipids; 1994 Jan; 67-68():115-9. PubMed ID: 8187205
[TBL] [Abstract][Full Text] [Related]
9. HDL enhances oxidation of LDL in vitro in both men and women.
Solakivi T; Jaakkola O; Salomäki A; Peltonen N; Metso S; Lehtimäki T; Jokela H; Nikkari ST
Lipids Health Dis; 2005 Oct; 4():25. PubMed ID: 16242018
[TBL] [Abstract][Full Text] [Related]
10. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects.
Raveh O; Pinchuk I; Fainaru M; Lichtenberg D
Free Radic Biol Med; 2001 Dec; 31(11):1486-97. PubMed ID: 11728821
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins.
Sattler W; Kostner GM; Waeg G; Esterbauer H
Biochim Biophys Acta; 1991 Jan; 1081(1):65-74. PubMed ID: 1825020
[TBL] [Abstract][Full Text] [Related]
13. Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membrane.
Engelmann B; Bräutigam C; Kulschar R; Duhm J; Prenner E; Hermetter A; Richter WO; Thiery J; Seidel D
Biochim Biophys Acta; 1994 Dec; 1196(2):154-64. PubMed ID: 7841179
[TBL] [Abstract][Full Text] [Related]
14. Resistance of lipoproteins from continuous ambulatory peritoneal dialysis patients to in vitro oxidation.
Serdyuk AP; Morton RE
Metabolism; 1997 Jul; 46(7):833-9. PubMed ID: 9225840
[TBL] [Abstract][Full Text] [Related]
15. Pyrene lipids as markers of peroxidative processes in different regions of low and high density lipoproteins.
Viani P; Cazzola R; Cervato G; Gatti P; Cestaro B
Biochim Biophys Acta; 1996 Mar; 1315(2):78-86. PubMed ID: 8608174
[TBL] [Abstract][Full Text] [Related]
16. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.
Vohl MC; Neville TA; Kumarathasan R; Braschi S; Sparks DL
Biochemistry; 1999 May; 38(19):5976-81. PubMed ID: 10320323
[TBL] [Abstract][Full Text] [Related]
17. Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.
Jürgens G; Fell A; Ledinski G; Chen Q; Paltauf F
Chem Phys Lipids; 1995 Aug; 77(1):25-31. PubMed ID: 7586089
[TBL] [Abstract][Full Text] [Related]
18. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis.
Hahnel D; Thiery J; Brosche T; Engelmann B
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2431-8. PubMed ID: 10521373
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane).
Thomas MJ; Chen Q; Franklin C; Rudel LL
Free Radic Biol Med; 1997; 23(6):927-35. PubMed ID: 9378372
[TBL] [Abstract][Full Text] [Related]
20. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation.
Neuzil J; Thomas SR; Stocker R
Free Radic Biol Med; 1997; 22(1-2):57-71. PubMed ID: 8958130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
